中商官网
研究报告
奥美医疗（002950）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2014 | 1509000000.0000 | 200000000.0000 | 232000000.0000 | 192000000.0000 | 1751000000.0000 | 1009000000.0000 | 742000000.0000 |
| 2015 | 1585000000.0000 | 169000000.0000 | 188000000.0000 | 153000000.0000 | 1848000000.0000 | 854000000.0000 | 994000000.0000 |
| 2016 | 1558000000.0000 | 284000000.0000 | 294000000.0000 | 248000000.0000 | 1898000000.0000 | 879000000.0000 | 1018000000.0000 |
| 2017 | 1711000000.0000 | 283000000.0000 | 282000000.0000 | 233000000.0000 | 2273000000.0000 | 1174000000.0000 | 1099000000.0000 |
| 2018 | 2028000000.0000 | 278000000.0000 | 276000000.0000 | 226000000.0000 | 2900000000.0000 | 1579000000.0000 | 1322000000.0000 |
| 2019 | 2352000000.0000 | 391000000.0000 | 394000000.0000 | 324000000.0000 | 3156000000.0000 | 1097000000.0000 | 2059000000.0000 |
| 2020 | 3834000000.0000 | 1342000000.0000 | 1339000000.0000 | 1160000000.0000 | 4856000000.0000 | 1933000000.0000 | 2923000000.0000 |
| 2021 | 2926000000.0000 | 506000000.0000 | 505000000.0000 | 432000000.0000 | 5005000000.0000 | 2253000000.0000 | 2752000000.0000 |
| 2022 | 4211000000.0000 | 525000000.0000 | 485000000.0000 | 405000000.0000 | 5748000000.0000 | 2617000000.0000 | 3131000000.0000 |
| 2023 | 2757000000.0000 | 169000000.0000 | 169000000.0000 | 104000000.0000 | 5084000000.0000 | 1873000000.0000 | 3211000000.0000 |
| 2024 | 3326000000.0000 | 458000000.0000 | 454000000.0000 | 369000000.0000 | 5059000000.0000 | 1611000000.0000 | 3448000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2014 | 14.71 | 15.37 | 13.25 | 33.7900 | 3.2300 | 8.68 | 0.86 |
| 2015 | 13.56 | 11.86 | 10.17 | 19.2500 | 2.9300 | -- | 0.86 |
| 2016 | 17.33 | 18.87 | 15.49 | 22.1900 | 2.7500 | 10.27 | 0.82 |
| 2017 | 15.43 | 16.48 | 12.41 | 20.7900 | 2.9700 | 10.96 | 0.75 |
| 2018 | 11.14 | 13.61 | 9.52 | 18.9500 | 2.7600 | 11.01 | 0.70 |
| 2019 | 13.18 | 16.75 | 12.48 | 17.7500 | 2.4400 | 11.09 | 0.75 |
| 2020 | 31.25 | 34.92 | 27.57 | 44.0000 | 3.1600 | 16.85 | 0.79 |
| 2021 | 13.74 | 17.26 | 10.09 | 15.6500 | 2.6300 | 8.82 | 0.58 |
| 2022 | 15.13 | 11.52 | 8.44 | 14.0900 | 3.2400 | 9.27 | 0.73 |
| 2023 | 4.86 | 6.13 | 3.32 | 3.5200 | 2.5100 | 6.41 | 0.54 |
| 2024 | 12.51 | 13.65 | 8.97 | 11.1800 | 3.5800 | 7.78 | 0.66 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2014 | 57.62 | 42.38 | 0.9600 | 0.5200 |
| 2015 | 46.21 | 53.79 | 1.3800 | 0.6400 |
| 2016 | 46.31 | 53.64 | 1.2900 | 0.7200 |
| 2017 | 51.65 | 48.35 | 1.2500 | 0.5100 |
| 2018 | 54.45 | 45.59 | 1.3000 | 0.5400 |
| 2019 | 34.76 | 65.24 | 2.6800 | 1.1800 |
| 2020 | 39.81 | 60.19 | 1.9400 | 1.1500 |
| 2021 | 45.01 | 54.99 | 1.3700 | 0.7800 |
| 2022 | 45.53 | 54.47 | 1.1600 | 0.6500 |
| 2023 | 36.84 | 63.16 | 1.3400 | 0.7100 |
| 2024 | 31.84 | 68.16 | 1.7400 | 1.0800 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2014 | 1287000000.0000 | 69072900.0000 | 163000000.0000 | 33225000.0000 |
| 2015 | 1370000000.0000 | 78264300.0000 | 134000000.0000 | 54915400.0000 |
| 2016 | 1288000000.0000 | 75303700.0000 | 135000000.0000 | 24587800.0000 |
| 2017 | 1447000000.0000 | 88498500.0000 | 165000000.0000 | 6716200.0000 |
| 2018 | 1802000000.0000 | 113000000.0000 | 181000000.0000 | 40565900.0000 |
| 2019 | 2042000000.0000 | 130000000.0000 | 230000000.0000 | 31094100.0000 |
| 2020 | 2636000000.0000 | 38204800.0000 | 252000000.0000 | -5961100.0000 |
| 2021 | 2524000000.0000 | 74471600.0000 | 295000000.0000 | -14314000.0000 |
| 2022 | 3574000000.0000 | 83796000.0000 | 366000000.0000 | 179000000.0000 |
| 2023 | 2623000000.0000 | 65691600.0000 | 324000000.0000 | 40439700.0000 |
| 2024 | 2910000000.0000 | 95911900.0000 | 282000000.0000 | 8380500.0000 |